FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149083651> ?p ?o ?g. }

• W2149083651 endingPage "1813" @default.
• W2149083651 startingPage "1800" @default.
• W2149083651 abstract "Background— Graft arterial disease (GAD) limits long-term solid-organ allograft survival. The thickened intima in GAD contains smooth muscle–like cells (SMLCs), leukocytes, and extracellular matrix. The intimal SMLCs in mouse GAD lesions differ from medial smooth muscle cells in their function and phenotype. Although intimal SMLCs may originate by migration and modulation of donor medial cells or by recruitment of host-derived precursors, the mechanisms that underlie their localization within grafts and the factors that drive these processes remain unclear. Methods and Results— This study of aortic transplantation in mice demonstrated an important function for chemokines beyond their traditional role in leukocyte recruitment and activation. Intimal SMLCs, but not medial smooth muscle cells, express functional CC chemokine receptor-1 (CCR1) and respond to RANTES by increased migration and proliferation. Although RANTES infusion in vivo promoted inflammatory cell accumulation in the adventitia of aortic allografts of wild-type and CCR1-deficient recipients, it increased GAD intimal thickening with SMLC proliferation in only the wild-type hosts. Aortic allografts transplanted into CCR1-deficient mice after wild-type bone marrow transplantation did not develop intimal lesions, which indicates that CCR1-bearing inflammatory cells do not contribute to intimal lesion formation. Moreover, RANTES induced SMLC proliferation in vitro but did not promote medial smooth muscle cell growth. Blockade of CCR5 attenuated RANTES-induced T-cell and monocyte/macrophage proliferation but did not affect RANTES-induced SMLC proliferation, consistent with a larger role of CCR1-binding chemokines in SMLC migration and proliferation and GAD development. Conclusions— These studies provide a novel mechanistic insight into the formation of vascular intimal hyperplasia and suggest a novel therapeutic strategy for preventing allograft arteriopathy." @default.
• W2149083651 created "2016-06-24" @default.
• W2149083651 creator A5002528258 @default.
• W2149083651 creator A5002803940 @default.
• W2149083651 creator A5002865209 @default.
• W2149083651 creator A5008055536 @default.
• W2149083651 creator A5043201732 @default.
• W2149083651 creator A5048579901 @default.
• W2149083651 creator A5061032580 @default.
• W2149083651 creator A5065331881 @default.
• W2149083651 creator A5073236797 @default.
• W2149083651 date "2009-11-03" @default.
• W2149083651 modified "2023-10-14" @default.
• W2149083651 title "CC Chemokine Receptor-1 Activates Intimal Smooth Muscle–Like Cells in Graft Arterial Disease" @default.
• W2149083651 cites W1517743926 @default.
• W2149083651 cites W1540778615 @default.
• W2149083651 cites W1545005818 @default.
• W2149083651 cites W1580577211 @default.
• W2149083651 cites W1648537547 @default.
• W2149083651 cites W1664507314 @default.
• W2149083651 cites W1682555806 @default.
• W2149083651 cites W180007238 @default.
• W2149083651 cites W1912592877 @default.
• W2149083651 cites W1971468252 @default.
• W2149083651 cites W1981903261 @default.
• W2149083651 cites W1985277568 @default.
• W2149083651 cites W1987945927 @default.
• W2149083651 cites W1990746956 @default.
• W2149083651 cites W1994853655 @default.
• W2149083651 cites W2007439146 @default.
• W2149083651 cites W2018500952 @default.
• W2149083651 cites W2021348213 @default.
• W2149083651 cites W2022050193 @default.
• W2149083651 cites W2037199982 @default.
• W2149083651 cites W2042394920 @default.
• W2149083651 cites W2048046765 @default.
• W2149083651 cites W2048345404 @default.
• W2149083651 cites W2054592961 @default.
• W2149083651 cites W2071276627 @default.
• W2149083651 cites W2071765103 @default.
• W2149083651 cites W2075303797 @default.
• W2149083651 cites W2077427214 @default.
• W2149083651 cites W2086483610 @default.
• W2149083651 cites W2091649591 @default.
• W2149083651 cites W2092907618 @default.
• W2149083651 cites W2099485659 @default.
• W2149083651 cites W2099768074 @default.
• W2149083651 cites W2118526748 @default.
• W2149083651 cites W2118678876 @default.
• W2149083651 cites W2121886052 @default.
• W2149083651 cites W2124328573 @default.
• W2149083651 cites W2127899118 @default.
• W2149083651 cites W2128148109 @default.
• W2149083651 cites W2137570167 @default.
• W2149083651 cites W2143631034 @default.
• W2149083651 cites W2146953630 @default.
• W2149083651 cites W2150703516 @default.
• W2149083651 cites W2152271058 @default.
• W2149083651 cites W2152339200 @default.
• W2149083651 cites W2160811521 @default.
• W2149083651 cites W2166028130 @default.
• W2149083651 cites W2167230971 @default.
• W2149083651 cites W2318624487 @default.
• W2149083651 cites W2334619796 @default.
• W2149083651 cites W4213297656 @default.
• W2149083651 cites W4248384150 @default.
• W2149083651 doi "https://doi.org/10.1161/circulationaha.109.859595" @default.
• W2149083651 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2996873" @default.
• W2149083651 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19841301" @default.
• W2149083651 hasPublicationYear "2009" @default.
• W2149083651 type Work @default.
• W2149083651 sameAs 2149083651 @default.
• W2149083651 citedByCount "18" @default.
• W2149083651 countsByYear W21490836512012 @default.
• W2149083651 countsByYear W21490836512013 @default.
• W2149083651 countsByYear W21490836512016 @default.
• W2149083651 countsByYear W21490836512018 @default.
• W2149083651 countsByYear W21490836512022 @default.
• W2149083651 crossrefType "journal-article" @default.
• W2149083651 hasAuthorship W2149083651A5002528258 @default.
• W2149083651 hasAuthorship W2149083651A5002803940 @default.
• W2149083651 hasAuthorship W2149083651A5002865209 @default.
• W2149083651 hasAuthorship W2149083651A5008055536 @default.
• W2149083651 hasAuthorship W2149083651A5043201732 @default.
• W2149083651 hasAuthorship W2149083651A5048579901 @default.
• W2149083651 hasAuthorship W2149083651A5061032580 @default.
• W2149083651 hasAuthorship W2149083651A5065331881 @default.
• W2149083651 hasAuthorship W2149083651A5073236797 @default.
• W2149083651 hasBestOaLocation W21490836511 @default.
• W2149083651 hasConcept C126322002 @default.
• W2149083651 hasConcept C12823836 @default.
• W2149083651 hasConcept C129013479 @default.
• W2149083651 hasConcept C13373296 @default.
• W2149083651 hasConcept C142724271 @default.
• W2149083651 hasConcept C189165786 @default.
• W2149083651 hasConcept C203014093 @default.
• W2149083651 hasConcept C2776716733 @default.
• W2149083651 hasConcept C2779751240 @default.

• next